Global Diabetic Retinopathy Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Global</strong> <strong>Diabetic</strong> <strong>Retinopathy</strong> <strong>Market</strong><br />
The <strong>Global</strong> <strong>Diabetic</strong> <strong>Retinopathy</strong> <strong>Market</strong> has been estimated at USD 6.1 billion in 2016 and is projected<br />
to reach USD 8.52 billion by 2021, at a CAGR of 6.9% during the forecast period from 2016 to 2021.<br />
Diabetes is a long-lasting disorder associated with defects in the secretion of insulin from the pancreas<br />
or hyperglycaemia associated to insulin resistance which eventually leads to long term multi-organ<br />
complications of nerves, eye, blood vessels, kidneys, and heart.<br />
The most common and severe sight threatening complication of diabetes is <strong>Diabetic</strong> <strong>Retinopathy</strong> (DR)<br />
which leads to damaging of the blood vessels present in the retina of the eye. The treatment procedure<br />
of diabetic retinopathy depends on the various stages of diabetic retinopathy. It is one of the most<br />
dominant reasons of blindness in adults globally.<br />
Full report at: http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathymarket-936/<br />
The growing incidence of diabetes coupled with increasing prevalence of blindness due to diabetes is<br />
expected to drive market growth over the forecast period. Increasing global geriatric population<br />
prevalence and strong awareness for early detection of diabetic retinopathy will be essential factors for<br />
driving global diabetic retinopathy market demand. However, dearth of skilled ophthalmologist<br />
combined with poor primary infrastructure is expected to restrain the market growth.<br />
The global <strong>Diabetic</strong> <strong>Retinopathy</strong> <strong>Market</strong> has been segmented on the basis of indication into Non-<br />
Proliferative <strong>Diabetic</strong> <strong>Retinopathy</strong> (NPDR) and Proliferative <strong>Diabetic</strong> <strong>Retinopathy</strong> (PDR). NPDR is further<br />
sub segmented as Mild, Moderate and Severe. Based on Treatment type the market is bifurcated into<br />
Anti-Vascular Endothelial Growth Factor (VEGF) drug, Intraocular Steroid Injection, Laser Surgery and<br />
Vitrectomy. By end users division is among Hospitals, Ophthalmic Clinics and Ambulatory Surgical<br />
Centers. Non-proliferative retinopathy dominated the overall market size estimated to lead the market.<br />
Augmented incidence of diabetes, lack of diagnosis at right time, and non-compliant retinal screening of<br />
diabetic patients are expected to boost the growth of non-proliferative diabetic retinopathy market<br />
share.<br />
Request sample: http://www.marketdataforecast.com/market-reports/global-diabetic-retinopathymarket-936/request-sample<br />
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin<br />
America and Middle-East and Africa. North America dominated the market followed by Asia-Pacific and<br />
Europe. The factors attributable for North America are having high obesity rates while Europe has large<br />
population of baby boomers. The emerging nations of Asia Pacific such as China and India are<br />
anticipated to witness significant growth during the forecast period owing to expanding geriatric
population base, increasing disposable income, innovation in diagnostics, rising research funding for<br />
diabetes and a large pool of patients.<br />
The Major companies in <strong>Diabetic</strong> <strong>Retinopathy</strong> treatment market are Bayer AG, Pfizer Inc., Hoffmann-La<br />
Roche ltd, Regeneron Pharmaceutical Inc., Novartis AG, Valeant Pharmaceutical International Inc.,<br />
Abbott Laboratories Inc., Alimera Science Inc. and Ampio Pharmaceuticals Inc.<br />
About <strong>Market</strong> Data Forecast:<br />
The publisher of this report is <strong>Market</strong> Data Forecast whose forte lies in <strong>Market</strong> research and Business<br />
Intelligence. Handling both individual and corporate clients across multiple business domains they offer<br />
syndicated/customized research to suit the client’s research objective. Their research reports section<br />
offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to<br />
product specific niche markets covering North America among other regions of the global market as well.<br />
For more info kindly visit, www.marketdataforecast.com<br />
Contact:<br />
Abhishek Shukla<br />
Sales Manager (International Business Development)<br />
<strong>Market</strong> Data Forecast<br />
Direct Line: +1-888-702-9626<br />
Mobile: +91 998 555 0206<br />
Mail: abhishek@marketdataforecast.com<br />
Visit <strong>Market</strong>DataForecast Blog @ http://www.marketdataforecast.com/blog/<br />
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Change language